Prophylactic Lamivudine to Improve the Outcome of Breast Cancer Patients With HBsAg Positive During Chemotherapy: A Meta-Analysis

CONTEXT: Raising the chemotherapy-induced HBV reactivation is parallel to the increment of chemotherapy treatments in breast cancer patients. This meta-analysis aims to evaluate the efficacy of prophylactic use of lamivudine in breast cancer patients with HBsAg positive during chemotherapy. EVIDENCE...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Yihu, Zhang, Shengchu, Tan Grahn, Hooi Min, Ye, Chao, Gong, Zheng, Zhang, Qiyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693540/
https://www.ncbi.nlm.nih.gov/pubmed/23805156
http://dx.doi.org/10.5812/hepatmon.6496

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693540/
https://www.ncbi.nlm.nih.gov/pubmed/23805156
http://dx.doi.org/10.5812/hepatmon.6496

Ejemplares similares